⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1008805 | 0.95 | — | — | |
| SCHEMBL1009514 | 0.87 | — | — | |
| SCHEMBL19348802 | 0.87 | — | — | |
| SCHEMBL30605 | 0.84 | TSHR (0.38) | — | |
| SCHEMBL1471539 | 0.80 | — | — | |
| SCHEMBL1075958 | 0.79 | LPAR2 (0.31) | — | |
| SCHEMBL7657268 | 0.78 | — | — | |
| SCHEMBL19348820 | 0.76 | LPAR3 (0.39) | — | |
| SCHEMBL87740 | 0.76 | — | — | |
| SCHEMBL5851977 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114728992-A | Method for producing phosphate compound | 斯泰拉化工公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-3222624-B1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO LTD (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-10287165-B2 | Imidic acid compound having divalent anion and process for producing the same | CENTRAL GLASS CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| EP-3222624-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | Central Glass Co., Ltd. (JP) | 2017-09-27 | — | — | EP | disclosed |
| US-20170267528-A1 | IMIDIC ACID COMPOUND HAVING DIVALENT ANION AND PROCESS FOR PRODUCING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2017-09-21 | — | — | US | disclosed |
| CN-104212799-A | Modulation of Factor 11 expression | ISIS PHARMACEUTICALS INC | 2014-12-17 | — | — | CN | disclosed |
| CN-102245186-B | Modulation of factor 11 expression | ISIS PHARMACEUTICALS INC | 2014-08-27 | — | — | CN | disclosed |
| CN-103820450-A | Modulation of factor 11 expression | ISIS PHARMACEUTICALS INC | 2014-05-28 | — | — | CN | disclosed |
| CN-102245186-A | Modulation of factor 11 expression | ISIS PHARMACEUTICALS INC | 2011-11-16 | — | — | CN | disclosed |
| EP-1798792-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE BATTERY HAVING SAME | BRIDGESTONE CORP (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20080153005-A1 | Non-Aqueous Electrolyte and Non-Aqueous Electrolyte Battery Comprising the Same | BRIDGESTONE CORPORATION (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-1798792-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE BATTERY HAVING SAME | Bridgestone Corporation (JP) | 2007-06-20 | — | — | EP | disclosed |